The drug CRV431 and the AI Power platform have both shown unmatched early positive results in a field in which there is a giant void to be filled: NASH. There are currently no drugs on the market for NASH, and CRV431 is already proving to be extremely positive in what little results we’ve been allowed to see.
There has been virtually radio silence from the company when it comes to the positive results thus far, which is another oddity similar to Dr . Hobbs. Normally, a company would be screaming from the rooftops how great its results are in order to attract more investors to raise additional capital. Not so here. Again this is all speculative, but it could indicate, along with the suppression of stock price and lockout period, that the price was suppressed in order to accumulate shares before revealing information that would skyrocket the price, and after the lockout period expiration.
Technicals looks good, the company has solid leadership, and their products have shown unparalleled results thus far. It’s trading at 52 week lows with seller fatigue completely set in with dried up. This is great entry point with tremendous upside potential.
Business News Governmental News Finance News